List of Vendor Companies in North Carolina - 105

410 Medical is a medical device company dedicated to developing innovative products that enable clinicians to improve care for critically ill patients. LifeFlow® PLUS, 410's recently approved product, is designed to enhance the speed and efficiency of volume resuscitation, improving care for patients with life-threatening conditions such as sepsis, hemorrhage and cardiac arrest.

Advanced Biological Laboratories (ABL), S.A., is a Medical Data Technology company founded in 2000 as a spin-off from CRP-Santé Luxembourg. ABL acquired all the patents and IP rights from TherapyEdge, Inc. in 2005 and in 2013 acquired the rights to all viral hepatitis B & C related assets from EVIVAR MEDICAL, respectively. ABL has a comprehensive suite of healthcare management products, including TherapyEdge®, ViroScore®, SeqHepB, DeepChek®, VisibleChek®, HepatiC™ and the DPM which are used for data and patient management, monitoring and personalized reporting applications. COVID-19: CE mark (07/2020)

AccuGenomics is a biotechnology company that specializes in a unique spike-in control technology to enhance the accuracy of clinical sequencing tests for low abundance biomarkers and infectious pathogens.

Develops a rapid leukocyte differential instrument is used to screen for infections, allergies, and blood-related cancers including leukemia.

AgBiomeis usingknowledge of the crop microbiome and an extensive network of field-sampling partners to build a proprietary microbial strain collection that is both diverse and large—larger, in fact, than the major public strain collections. Unlike many programs, which only use metagenomics surveys, the AgBiome platform is focused on true isolated microbial strains, which provideinsight into the genomic composition of crop-associated microbes. The company uses this collection as a resource for discovering new biologicals and trait genes.Existing microbial classification systems based on 16S rDNA sequences or other fingerprinting technologies are imprecise—microbes that are classified as ‘the same’ often differ by hundreds of genes. AgBiome uses proprietary algorithms based on whole genome sequence to classify organisms in their collection. This allows the company to measure the true diversity of plant-associated microbes at the gene level—and genes determine function and performance. The company has also applied our whole-genome methods to their straincollection.

Alcami is a pharmaceutical CDMO that offers contract development and manufacturing services for the healthcare and biotechnology industries.

ARC specializes in mass culturing of sensitive marine and freshwater microalgae that are challenging to grow on a large scale. We are also experts in finding the proper medias for difficult to culture species and isolating species from wild samples. Our main group of focus are dinoflagellates, but we have recently expanded our services to include diatoms, such as Haslea sp., and freshwater species, such as the green algae Oophila sp. ARC also provides toxin analysis, DNA extraction and sequencing, photomicrographs, and HPLC pigment analysis. Feel free to contact us at arc.uncwilmington@gmail.com or view our website for service pricing and available strains.

Asensus Surgical is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™ by unlocking the Clinical Intelligence to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance® Surgical System powered by the Intelligent Surgical Unit™ (ISU™) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. Learn more about Performance-Guided Surgery and Digital Laparoscopy with the Senhance Surgical System here: www.Senhance.com. Now available for sale in the US, EU, Japan, Russia, and select other countries. For a complete list of indications for use, visit: https://www.senhance.com/indications.

Aseptic Technologies develops, manufactures and markets equipment that guarantee optimal sterility assurance level and complies with latest regulatory requirements, while simplifying the validation and operation processes in the safest way. Aseptic Technologies improves the quality of aseptic operations by providing user-oriented and really innovative state-of-the-art equipment and services to the pharmaceutical industry.

At Asterra Labs, we are pharmaceutical scientists and industry veterans with a passion to innovate, develop, and manufacture a pharmaceutical-grade line of safe, beneficial wellness products and alternative medicines.

Atlantic Fish Company is working to make cultivate seafood. Cells are harvested from the fish and fed nutrients in a bioreactor. Scaffolding is used to give the cells a structure to grow on and produce the texture of a whole fish fillet. The end product is REAL seafood, grown directly from fish cells.

Avazyme, Inc. a contract research solution provider, offering field and laboratory testing, product development, and expert consulting services to the agriculture and food industries. Avazyme's comprehensive services include food safety analyses for contaminants, pathogens, allergens, food quality and nutrition analysis, genetic trait testing, product safety, FDA Menu Labeling, pesticide residues, mycotoxin analysis, specialized studies for regulatory submission data packages, and a full spectrum of testing for product safety and product quality related to Industrial Hemp. Avazyme provides fast and reliable answers to ensure product safety and high product quality for consumable food, feed, cosmetics, nutraceutical Avazyme also offers comprehensive laboratory and "​in-brewery"​ services to craft breweries and local hops growers and maltsters. Most recently, Volker and his Avazyme team have been a strong supporter and testing partner for the fast-emerging Industrial Hemp Industry in North Carolina and the entire East Coast

Baebies Inc. is a growth-stage medical device company developing innovative products to enable early disease detection and multifunctional diagnostics for syndromic testing for children and adults. Guided by the vision that everyone deserves to be healthy, we aim to deliver ‘Any test. Anywhere. To Everyone.’ We deliver millions of tests globally every year to save lives and make lives better. Baebies is a pioneer in digital microfluidics technology, which maximizes diagnostic yield from low-volume samples. Baebies is headquartered in Durham, North Carolina, and our products are used in central laboratories and point-of-care settings around the world. Over 20 million tests delivered, and counting. Every test is a chance to save a life. Our current pipeline of test panels on the multifunctional FINDER platform include molecular (Respiratory panel - Flu A, Flu B, RSV, and SARS-CoV-2, STI panel - CT/NG/TV), coagulation (anti-factor Xa, aPTT), and chemistry (G6PD).

BA Sciences is a cGMP compliant, FDA/DEA registered, ISO/IEC-17025:2017 certified analytical laboratory located in Salem, NH. BA provides testing services to Pharmaceutical, Biopharmaceutical and Medical Device companies worldwide including: Analytical Testing and Method Development, Microbiological Testing and Environmental Monitoring Services, Biologics, Stability Testing & ICH-compliant Storage, Impurities Testing, Advanced Therapeutics and Extractables & Leachables Studies.

Purpose-built for organizations conducting clinical trials and observational studies, we leverage our AI-powered patient-matching platform and clinical expertise to optimize feasibility and speed up patient identification by extracting structured and unstructured data from electronic medical records (EMRs) that captures three times more trial criteria. Why: We believe sites are vital to the success of clinical trials. Empowering them to find the right patient for the right research at the right time is the focus of everything we do. What: We leverage our best-in-class technology and data expertise to detect more protocol-eligible candidates than traditional methods, so that site teams can focus on the parts of the job they actually love. How: We deliver an AI-powered software platform and support from clinical experts that enables our customers to find and match patients to available clinical research. With unbelievably fast and highly-accurate data extraction from electronic medical records (EMRs) we can capture three times more trial criteria - making trial participation more accessible and efficient.

BioAgilytix is a biotechnology company that specializes in bioanalysis for the biopharmaceutical and life sciences industries.

Biolink LifeSciences is a premier contract research organization offering a comprehensive range of services including synthesis, characterization, formulation development, and analytical services for small to large molecules for nearly all dosage forms. Our strength resides with our highly experienced team in synthetic chemistry, analytical method development & validation and formulation development to solve difficult problems.

Biomason is a unique biotechnology start-up manufacturing company with a natural process that will revolutionize the building and construction industry. Biomason employs natural microorganisms and chemical processes to manufacture biological cement-based masonry building materials.Biomasonmakes biocement by usingBacillus to hydrolyze urea. This process producesCO2, whichcombines with calcium ions to form calcium carbonate. This process binds particles of sand and rock together to make tiles.

BIOMILQ is a women-owned and science-led mammary biotechnology start-up leveraging its patented technology to produce functional cell-cultured human milk components outside the body. With the goal of bridging the gap between breast milk and infant formula, BIOMILQ aims to revolutionize early-life nutrition by bringing more of the benefits of breast milk to more babies.

BioSkryb is a venture-backed startup bringing new solutions for cellular heterogeneity, in both the research and clinical space studies, using a proprietary genome amplification system.

BMG LABTECH is a leading developer and manufacturer of microplate reader instrumentation with a wide range of measurement methods. Microplate readers are used in the pharmaceutical and biotech industries, as well as in academic research establishments, for both basic research analysis and high-throughput screening. We focus solely on microplate readers and offers the most diverse selection of optical detection systems in conjunction with integrated liquid handling equipment. Our exceptional worldwide sales and support network is committed to bringing you innovative microplate reader technology with the reliability and quality that you expect from BMG LABTECH. The highest priority at BMG LABTECH is to have satisfied microplate reader customers! We succeed at this goal by not only offering excellent microplate readers but also providing personal customer support that not found at larger companies. Our support centers have teams of microplate reader development specialists ready to work with you and your applications to get the most out of your microplate reader. This close working relationship allows BMG LABTECH to completely understand your needs and to help develop our instruments to meet the changing needs of the microplate reader market. Imprint: https://www.bmglabtech.com/legal-notice/ Privacy Policy: https://www.bmglabtech.com/privacy-statement-linkedin/

Caidya is a multi-therapeutic clinical research organization (CRO) serving innovators worldwide. Focused on delivery excellence and an elevated customer experience, Caidya offers a wide range of clinical services and vast therapeutic expertise, supporting its partners from pre-IND strategy, through clinical development to submission and post-marketing surveillance. Caidya leverages industry-leading and proprietary clinical technology to ensure trial transparency and data-driven decision-making. Formed in 2021 following the combination of leading CROs, dMed and Clinipace, Caidya has nearly 1,800 employees in more than 30 countries throughout the world.

CAMAG is the world leader in High-Performance Thin-Layer Chromatography. We provide high-end instruments, tools and concepts for TLC/HPTLC. Additionally, we support our clients with training, technical and contract laboratory services. Wherever complex substance mixtures are analyzed (e.g. herbal, environmental or forensic samples), TLC/HPTLC often is an excellent alternative to GC and HPLC. Moreover, it has proven value as a solid quantitative analysis technique in quality assurance of food, pharmaceuticals and other industrial products. Since 1961, CAMAG is dedicated to the development and manufacturing of instruments, software and consumables for all steps of the TLC/HPTLC procedure. Our products are truly Swiss made and have an excellent reputation throughout the world.

Carolina Liquid Chemistries (CLC) helps clinical laboratories of all sizes reduce reagent costs and get accurate, timely results. CLC is a leading provider of chemistry instruments and reagents for use in reference laboratories and clinical laboratories in hospitals, laboratories in physician offices, and veterinary facilities. CLC offers a complete line of clinical chemistry analyzers and over 100 general and toxicology (urine drug screen) reagents. CLC offers our branded line of reagents, instruments, services, training, and validation assistance. Our chemistry analyzers include: • CLC6410 • CLC1600 • CLC800 • CLC480/BiOLiS 24i We are a privately held, veteran-owned, ISO-certified company, and an FDA-registered manufacturer, re-packager, and re-labeler of chemistry analyzers and related products. For over 25 years, we have brought multiple reagents for a variety of chemistry instruments and reagents to market. We have served nearly 2,000 customers worldwide and are committed to helping laboratories reduce costs and get accurate, timely results.

Celldom is developing next generation, high throughput single cell analysis technology to advance research, drug discovery, and drug development by illuminating diversity in cell populations. The company's cloneXplorer and proprietary nanowell plates uniquely integrates both phenotypic and genomic data at massive scale (up to 100,000s of cells per experiment) to identify and characterize rare cells that play critical roles in biological pathways and disease. Celldom is developing initial applications of the platform in the areas of oncology, immunology and stem cell biology. Learn more at www.celldom.com and follow the company's growth @celldominc on Twitter.

Lifechanging breakthroughs like cell and gene therapy are driving a medical revolution. But a lack of purpose-built development and manufacturing tools keeps these treatments from reaching more patients. At Charter Medical, we're on a mission to evolve single-use cell processing step-by-step with the needs of the biopharmaceutical innovators who count on us. With proven customization capabilities and an innovation roadmap that includes pioneering design and biomaterials. With industry-leading expertise and continuous improvement to simplify and standardize biomanufacturing systems so they can scale reliably. And with a deep commitment to responsiveness, collaboration and urgency. Because we know single-use advances are essential to helping our clients make revolutionary therapies more accessible to patients who need them – now.

CiVentiChem is a premier Contract Development and Manufacturing Organization (CDMO) with over 30 years of experience serving the pharmaceutical and specialty chemical industries. We operate two facilities in India, specializing in medicinal chemistry, process chemistry, and the manufacturing of Regulatory Starting Materials (RSMs) and intermediates. Our team’s expertise allows us to support projects at every stage, from early drug discovery to full-scale commercial production. In 2019, we successfully sold our GMP kilo-lab in Cary, North Carolina, to Sterling Pharma, further focusing our efforts on expanding our global manufacturing capabilities. In 2024, we made significant investments to increase our production capacity, enabling us to manage programs ranging from gram-scale synthesis to multi-ton manufacturing. To better serve our U.S. clients, we maintain an office in Cary, North Carolina, which facilitates the seamless shipping and receiving of materials from India. CiVentiChem is committed to delivering simple solutions to complex chemistry challenges across all phases of drug development.

Codetta Bio is a company developing an integrated platform for highly multiplexed, quantitative, simultaneous multi-omic analyses of nucleic acid and protein assays. They are focused on precision medicine and accelerating clinical success through their advanced multi-omic biomarker measurement tools.

CSL Plasma is one of the world’s largest collectors of human plasma. We are committed to excellence and innovation in everything we do. Our work ensures that tens of thousands of people with rare and serious diseases are able to live normal, healthy lives. We are committed to our work because people’s lives depend on us. See our community guidelines: https://bit.ly/2IApjpz. Supported by parent company CSL Behring, the global leader in plasma protein biotherapeutics, CSL Plasma has more than 280 plasma collection centers globally. CSL Plasma also has a state-of-the-art testing laboratory that features some of the most advanced technology, instrumentation and automation in the field; two logistics centers, one in Dallas and one in Indianapolis. Our corporate headquarters in Boca Raton, Florida. Our U.S. plasma collection centers are committed to the highest standards of quality and safety. When you donate, you give a valuable gift to those who require plasma-derived therapies to live healthier lives. The CSL Group has a combined heritage of outstanding contribution to medicine and human health with more than 100 years experience in the development and manufacture of vaccines and plasma protein biotherapies. With major facilities in Australia, Germany, Switzerland and the US, CSL has over 30,000 employees working in more than 35 countries. See our community guidelines: https://bit.ly/3QZbZeZ

Cygnus Technologies, part of Maravai LifeSciences, is the biopharmaceutical industry’s partner in host cell protein (HCP) and other process-related impurity detection and analytics. In addition, Cygnus now provides innovative viral clearance solutions as well. Cygnus helps companies developing therapeutic proteins, vaccines, antibodies, plasma derivatives and gene therapies to ensure the safety of biotherapeutics prior to human trials, regulatory approval and commercial release. Cygnus provides analytical tools and solutions delivering insights to improve bioprocess development for faster regulatory approval and better clinical outcomes. Cygnus is an industry pioneer responsible for developing and commercializing the first generic assay kits for HCP detection. Its reputation for quality is recognized by the industry and global regulatory agencies. It continues to advance the science of bioprocess impurity detection with new breakthroughs, including its Antibody Affinity Extraction™ (AAE) technology and orthogonal methods of HCP analysis that integrate Mass Spectrometry, AAE and ELISA. To reduce the cost and risk associated with viral clearance studies, Cygnus also offers a unique approach that utilizes non-infectious mock virus particles through its MockV™ virus clearance kits. Cygnus’ proprietary technology, available through its off-the-shelf and custom analytics programs, sets the gold standard for enabling HCP and other bioprocess impurity antibody assays. Cygnus delivers best-in-class customer service and technical expertise, operational excellence and ISO-9001:2015 certified quality management systems. Founded by Ken Hoffman in 1997, Cygnus continues to support and advance technology in order to improve biotherapeutic safety and accelerate the movement of new therapeutics through the development and regulatory approval process. Located in Southport, North Carolina, Cygnus Technologies is online at www.cygnustechnologies.com.

With more than 20 years of industry experience and go to market expertise, Daily Manufacturing has set itself apart as a leader in helping businesses develop, create, and package products in the personal care, cosmetic, and health & wellness space. Our passionate team is committed to creating and delivering the highest-grade products possible without compromising on ingredients, packaging, or production techniques. Having seen rampant quality control and manufacturing issues in our industry, we set out to establish a best in class 45,000sq ft production facility located in Southern California, making products for global brands and small startups looking for a production partner they can trust and who can scale with their needs.

DHMRI is a 501(c)(3) non-profit, contract research organization specializing in the provision of cutting-edge genomic and metabolomic research services and instrumentation essential to furthering scientific understanding in areas including human health, nutrition, immuno-oncology, plant and animal trait development, and microbiome studies.The organization leverages its expertise and world-leading facilities through scientific collaborations with researchers and other non-profit organizations, world-wide, to deliver advancements in theknowledge and understanding of human wellness, health and longevity.As part of its mandate, DHMRI also provides an integrated core laboratory serving the North Carolina Research Campus (NCRC) and North Carolina university researchers, with cutting edge technologies, and services.

Duke University spin-out, Deep Blue Medical Advances has developed a novel hernia mesh to address the unacceptably high rate of hernia occurrence and recurrence. Millions of hernia surgeries are done globally with billions of dollars in clinical cost. Our surgeon-invented T-Line® Hernia Mesh with integral suture-like extensions is designed to eliminate a key point of failure for conventional mesh fixation - the mesh, suture, tissue interface - and to provide superior anchor strength. In addition, several additional products are in development, including an anchor clip for even faster, easier implantation; a biosynthetic version of the T-Line Hernia Mesh; and a coated composite version of the T-Line Mesh. Deep Blue products enhance hernia surgery with a potentially significant impact on the $1.1B global hernia device market. Due to its simple yet revolutionary design, the T-Line® Hernia Mesh has the potential to reduce hernia occurrence and recurrence by preventing or reducing mesh fixation failure.

DNAli is a biotechnology company that specializes in unlocking the full world of DNA through low-cost production of best-in-class DNA.

Elo Life Systems is reimagining the future of food – focusing on ingredients that empower consumers to feel good about the food they eat every day. From unique plant-based sweeteners to saving crops like the banana from extinction, Elo harnesses the untapped potential of nature to make food tastier, healthier and resilient while requiring less from the planet.

As the nation's leading environmental testing firm, EMSL's network of nationwide laboratories has been providing quality analytical services since 1981. We offer a wide array of analytical testing services to support environmental investigations focused on asbestos, microbiology, lead paint, environmental chemistry, indoor air quality, industrial hygiene and food testing. Additionally, we also provide materials testing, characterization, and forensic laboratory services for a wide range of commercial, industrial, regulatory, and law enforcement clients. Our unmatched capacity coupled with a company wide focus on customer satisfaction makes no project too large or too small. Our corporate research and development capabilities allow us to bring new methodologies on line quickly to meet new industry challenges and client needs. In recruiting and retaining talented and motivated scientists on a national scope, our expertise is marshaled throughout a nationwide network of analytical laboratories. We are committed to providing reliable, defensible data in a standardized and user-friendly format. Rapid turnaround and competitive prices make the dependable results you get that much more valuable. At EMSL, we're much more than another testing laboratory. We are your project partner!

Entegrion identifies, invents and systematically develops device and biological technologies to meet clearly defined medical needs. Our pipeline is distinguished by its uniqueness--- we pursue areas with limited competition and profound needs. We design efficient and focused development plans to assure that the products we deliver perform as intended and are ready for market. Twitter @entegrioninfo

A pioneer in the field of epigenetics and chromatin biology, EpiCypher is a bioscience company developing transformative technologies and delivering superior products to researchers world-wide. Our technologies and products are making studies possible that were not imaginable just a few years ago. Our renowned chromatin researchers possess expertise and unique insight into chromatin biology and drug discovery that benefit our customers in ways other companies cannot. Epigenetics, the study of changes in heritable traits that occur independent of alterations in changes in the underlying DNA sequence, is an emerging and important area of biomedical research with broad impact on human health and disease.

Exela Pharma Sciences LLC is a specialty pharmaceutical company based in Lenoir, North Carolina, founded in 2005. The company develops, manufactures, and markets both generic and proprietary sterile injectable and ophthalmic products. Exela aims to improve patient outcomes and reduce healthcare costs through its innovative offerings. With a workforce of 501–1,000 employees, Exela specializes in products that face high barriers to market entry, utilizing regulatory pathways like Abbreviated New Drug Approvals (ANDA) and 505(b)(2) submissions. The company focuses on delivering high-quality, affordable products that enhance the experiences of healthcare providers and patients, emphasizing ease of use and clinical effectiveness. Exela's product range includes sterile injectables designed for improved safety and faster preparation, as well as sterile ophthalmic solutions that meet strict regulatory standards. The company operates a vertically integrated model, managing development, manufacturing, and commercialization in-house, which supports its commitment to quality control and innovation in the pharmaceutical industry.

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea's solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.

Frontier Scientific Solutions (FSS) is a contract service organization (CSO) which supports the life science industry by offering cGMP temperature-controlled storage, distribution, and logistic services. Drug development and commercialization require continuous temperature monitoring and control. Frontier's diverse offerings protect product integrity throughout the pharmaceutical supply chain. FSSs' validated software, cGMP storage and drug distribution facility, industry expertise and stringent quality standards support this objective throughout packaging, storage and distribution.

A leading herbal brand in North America, Gaia Herbs cultivates health and wellbeing by stewarding sustainable relationships between plants and people. Our unparalleled dedication to purity, integrity and potency is meticulously proven by science. We use organic methods from seed to shelf and pioneered the industry's first transparency program, MeetYourHerbs®. We are proudly based in the beautiful mountains of Western North Carolina.

Gilero offers end-to-end device design, development and contract manufacturing in the medical and pharmaceutical industries. Specializing in the areas of consumable and reusable medical devices, drug delivery, combination products and complex electromechanical systems, Gilero offers a wide range of services to meet your medical or drug delivery device needs.

H&A Scientific, Inc. is a scientific software development firm specializing in pharmaceutical industry support. We develop, validate, and market quality computing systems for scientific data acquisition, processing, and data management. We have been creating programs for the laboratory since 1992. Our products have been designed under our Quality System to adhere to the current GAMP guidelines. We develop Quality Software products based on the needs of pharmaceutical companies subject to the constraints and compliance of the Food and Drug Administration (FDA). Our flagship product, SLIM, is a commercial off-the-shelf solution for total management of a company's drug stability program. Learn more about us: https://www.youtube.com/watch?v=_GZ9PQ9d4dI

HemoSonics is breaking new ground in point-of-care Viscoelastic #hemostasis testing. When time is critical, the Quantra® QPlus® System offers rapid, accurate, and easy to understand results that enable clinicians to make more informed #transfusion decisions, more quickly. This novel, cartridge-based POC VET system now has De Novo marketing authorization in the USA and is intended to assess the coagulation status of perioperative patients at the point of care. Follow us at @HemoSonics

The company is developing probiotics and enzymes that improve cattle health and digestive efficiency by eliminating methane.

Hydromer® is a leading global surface modification and coatings solutions provider. As a trusted partner to companies worldwide, our solutions add value to our clients’ products so that they can stand out in the marketplace. We are an innovation-driven, customer-centered organization with a focus on meeting our clients’ needs. Hydromer collaborates extensively with clients to deliver superior, customized polymer-based solutions. We create or modify coating formulations that adhere to a multitude of substrates and match the unique requirements and geometries of any device. We are a leader in developing coating formulas and processes that meet a market-driven need for greener, more sustainable solutions. We offer custom industrial and medical device coatings, contract coating services, customized coating equipment, contract manufacturing, and turnkey operations backed by outstanding teams of research and development, customer service, and tech support. Hydromer® has been a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for over 40 years. As a trusted partner to large and small companies worldwide, our solutions add value to our clients’ products so that they can stand out in the marketplace. We are an innovation-driven, customer-centered organization with a focus on meeting our clients’ needs. We are a GMP/ISO 13485 and ISO 9001 production facility located in Concord, North Carolina.

We are your worldwide manufacturer of quality polyclonal antibodies used in research and in vitro diagnostics. We have a wide range of secondary antibodies covering a broad spectrum of immunoglobulins from various species and cross absorbed to provide high specificity. We are also your source for primary polyclonal antibodies to hormones, cancer markers, cardiac markers and serum proteins. In addition to our product lines, we offer custom absorptons and purifications to meet specific requirements, yet knowledgeable and experienced to provide bulk manufacturing within cGMP guidelines and ISO quality systems requirements.

Surgical software

IQVIA applies data science to the continuous advancement of human science to make health care decisions more precise, relevant, and even creative.

Isolere's mission is to increase global access to life-changing therapeutics and vaccines by offering novel purification reagents to alleviate manufacturing bottlenecks. The IsoTag™ reagents reimagine bioprocessing by combining target specific affinity ligands with phase separating biopolymers. The Affinity Liquid Phase Separation (ALPS) allows target biologics to be separated on the basis of affinity and size in a single process and can be implemented in a variety of techniques including microfiltration TFF and centrifugation processes. Isolere is currently developing purification solutions for adeno-associated virus (AAV), lentivirus (LV), adenovirus (AdV) and mRNA. Visit our website to learn more! Isolere Bio was acquired by Donaldson Company, Inc. (NYSE: DCI), a leading worldwide provider of innovative filtration products and solutions, in February 2023.

Jellatech is a B2B biotech business based in Raleigh, NC producing human proteins for advancements in health using our unique cell-based technology. By unlocking the production of complex proteins at scale, Jellatech is enabling the creation of new possibilities for health and longevity, starting with Type I collagen. Jellatech’s mission is to revolutionize biomedical applications through cutting-edge, human-identical proteins. Jellatech enables advancements in tissue regeneration, injectable aesthetics, cell and gene therapy, and various therapeutic applications by supplying human-identical collagen and complex proteins. With all of it's known limitations, the tissue-extracted bovine and porcine medical grade collagen market for biomedical applications is expected to surpass $2.4B by 2032; however, with the introduction of a viable supply of human collagen across key verticals, the total addressable market (TAM) for human collagen alone could surpass $100-150 billion in the near future. Why Jellatech? Jellatech's platform is the only solution to deliver a reliable, consistent supply of bio-identical, fully functional human type I collagen for biomedical applications. Contact us to learn more. This is just the beginning. The potential is vast, and we’re here to help companies achieve breakthroughs in healthcare and beyond. Join us in unlocking a brighter future.

Great software in the right hands can change the world. We’ve seen it. You may have too. JMP products are behind many of the world’s greatest green-energy technologies, pharmaceutical breakthroughs, and high-tech improvements. For 30-plus years, JMP statistical software products have helped users see data clearly. It’s spelled J-M-P but pronounced “jump,” suggesting a leap in interactivity, a move in a new direction. Our purpose is to empower scientists and engineers via our statistical discovery software. Although our purpose is clearly connected to our software, it doesn’t end there. As an employer, JMP purposefully creates and maintains a culture of camaraderie that allows the personalities of our diverse and inclusive employee base to shine through. JMP is an equal opportunity employer. If you’re considering a career move, check out JMP Statistical Discovery. JMP employees live and work across the Americas, Europe, and Asia. Our business is growing, our employees are engaged, and our work is rewarding. JMP is a SAS company. Read more: www.jmp.com/about

Jubilant Pharma Limited is a global integrated pharmaceutical company offering a wide range of products and services to our customers across geographies. We organize our business into two segments, namely, Specialty Pharmaceuticals, comprising Radiopharmaceuticals (including Radiopharmacies), Contract Manufacturing of Sterile Injectables and Non-sterile Products and Allergy Therapy Products, and Generics & APIs, comprising Solid Dosage Formulations and Active Pharmaceutical Ingredients.

KBI Biopharma is an award-winning biopharmaceutical contract services organization providing fully-integrated, accelerated drug development and biomanufacturing services to pharmaceutical and biotechnology companies globally. With each of our 500+ client partners, we have worked closely to personalize and rapidly accelerate their drug development programs. Built upon a foundation of world-class analytical capabilities, we deliver efficient process development and clinical and commercial cGMP manufacturing services for mammalian and microbial programs. KBI is proud to be a JSR Life Sciences Company.

Keel Labs™ began in 2017 as AlgiKnit, creating ocean-focused materials built from renewable resources. In 2022, Keel Labs was established as a platform for innovation, broadening our vision for the potential of the ocean to accelerate our planet's development towards a more sustainable future. Driven by the exploration of novel resources from the ocean, Keel Labs™ functions as a hub for the next generation of climate-focused solutions derived from nature. So, though our name has changed, our mission remains the same: Keel Labs™ works at the nexus of design, science, and engineering to create impact-driven materials harnessing the power of the ocean.

KSE Scientific is a Bioprocess manufacturer specializing in the production of sterile products for the Tissue Banking, Pharmaceutical, and Biotech industries.

Kymanox (‘ki-mah-noks'), meaning Ideal Knowledge Transfer, advances life science innovation through insightful solutions and collaboration. We do this by accelerating the design and commercialization of modern medicines for our customers using integrated engineering, scientific, compliance, and project management solutions that are insightful, collaborative, and comprehensive. By building and supporting the development of modern medicines, Kymanox has proven, end-to-end solutions that are helping bring better Life Science Products to the market- and keep it there. We do all of this with heart and pride… because patients deserve better. Kymanox, founded in 2004, serves clients from Fortune 100 companies to virtual start-up companies all across the globe. Headquartered in Research Triangle Park, NC, we have US offices in Boston and Philadelphia, and since 2022 have expanded to Germany, Switzerland, and Israel.

Levee Medical, Inc. designs, develops, and manufactures innovative urological devices with the focus of improving recovery outcomes post-prostatectomy so that patients can quickly and confidently return to normal activity. The company's inaugural product is designed to support and stabilize the post-operative bladder neck and urethra following prostatectomy to accelerate the return of continence and reduce the overall risk of chronic incontinence.

LigaTrap has developeda patented portfolio of affinity ligands that can be used to purifymonoclonal and polyclonal immunoglobulins from various species.

MacVector is a comprehensive Macintosh sequence analysis application that provides sequence editing, primer design, internet database searching, protein analysis, sequence confirmation, multiple sequence alignment, phylogenetic reconstruction, coding region analysis, agarose gel simulation and a variety of other functions.

Marken is the clinical precision logistics and advanced therapy subsidiary of UPS Healthcare. The UPS Healthcare network consists of 200+ locations worldwide. Marken offers a state-of-the-art GMP-compliant depot network and logistic hubs for clinical drug product storage and distribution in 46 locations worldwide, while maintaining the leading position for cell and gene therapy services, direct-to-patient and home healthcare services, biological sample shipments and biological kit production. Marken's dedicated 2,600+ staff members manage 200,000 drug product and biological sample shipments every month at all temperature ranges in more than 220 countries and territories and have orchestrated 17,500+ home healthcare visits. Additional services such as ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken's unique position in the pharma and logistics industry. Delivering What Matters From Clinical to Commercial.

Marc Clark is a medical research company that focuses on conducting clinical trials and providing resources for clinical trial volunteers.

Almost every factor that affects health – from genetics and the microbiome to disease and lifestyle – exerts its influence by altering metabolite levels in the body or other biological system. By producing the most accurate and comprehensive picture of the collection of metabolites, known as the metabolome, from a single biological sample, Metabolon can deliver an instantaneous snapshot of the entire physiology of a living being at a discreet point in time, as well as identify changes in that system brought about the impact of disease, medical intervention, diet or the environment. This deep and comprehensive view of the metabolome provides biological insights that cannot be revealed through any other research methodology, enabling life sciences researchers and drug developers to discover answers some of biology’s most difficult questions. Metabolon's unrivaled capability to look deep into the metabolome has enabled us to build the world’s largest library of compounds that currently includes 5,200+ total known molecules. Our proprietary Precision Metabolomics™ platform, combined with the world's most experienced metabolomics scientists, delivers biologic insights and identification of novel commercial opportunities for drug discovery and development, through clinical trials and life cycle management. Metabolon’s expertise is also accelerating research and product development for clients in academia, population health, consumer products, and nutrition industries. Founded in 2000 and based in Research Triangle Park, North Carolina, Metabolon has conducted more than 10,000 independent and collaborative studies, resulting in 2,000+ publications in leading peer-reviewed journals. For more information about our technology, products and services, please visit www.metabolon.com.

Mimetics is devoted to building and maintaining a world-class suite of analytical tools for investigating the dynamics of biological networks.

mPATH is a B2B software-as-a-service company that improves healthcare organizations' bottom line with an automated platform that closes preventive care gaps. mPATH™ is a low-cost, cloud-based program that identifies individuals who are overdue for routine screening tests, provides personalized education, and connects patients with needed care. We believe that healthcare shouldn't be confined to a doctor's office. With its cloud-based design, mPATH™ reaches patients wherever they are and when they want.

The global leader in continuous flow thermal sterilization. MTI Bioscience services the biotech, biopharmaceutical manufacturing, and biofuel industries for sterilization of growth media.

Nitta Gelatin produces pharmaceutical and food-grade gelatin for a variety of uses in the pharmaceutical industry.

North Carolina Clinical Research (NCCR) is an independent, multi-therapeutic outpatient clinical research site located in Raleigh, North Carolina. NCCR has conducted Phase I, II, III and IV clinical trials in both children and adults since 1986. We have completed over 530 studies in a variety of therapeutic areas for many different pharmaceutical companies and Clinical Research Organizations (CROs). NCCR is dedicated 100% to Clinical Research. We have a dedicated staff that makes our facility stand out above the rest. Our hardworking, passionate, and friendly crew makes studies placed at NCCR a positive experience for both the sponsor and the patient. Supporting our principal investigators in the completion of each study is a clinical research staff of more than 18 professionals including Sub-Investigators, Site Manager, Subject Recruiter, Regulatory Administrator, Clinical Research Coordinator, and Office Coordinator. Our team has over 225 combined years of Clinical Research experience. Our facility is located across the street from a major medical center, and we have access to a metropolitan population exceeding one million. We are also located near three major universities: North Carolina State, Duke, and UNC-Chapel Hill. Our facility includes a fully equipped lab, secured storage for ambient and refrigerated study drug, a patient lounge area for extended days, and overnight facilities with showers and individual sleep areas.

Supporting biotech companies from innovation to impact. Specialized clinical development solutions with dedicated teams. IQVIA Biotech is a CRO strategic problem-solver with therapeutic expertise.

Novex Innovations is a true CDMO (Contract Development/Manufacturing Organization) supporting our clients efforts in the commercialization of their products. Our areas of operation include: Biological Formulations Clinical Formulation Tissue Processing Bioengineered Tissue Active Pharmaceuticals Diagnostic Materials Medical Devices Development to Pre-Clinical to Commercial Regulatory Support Storage & Distribution & Order processing services. Scale-up optimization Product characterization Manufacturing through all phases of clinical trials Commercial modeling, manufacturing, and distribution Proof of concept Our clients range from single person operations to multinational companies. We provide process development, manufacturing, storage, and product distribution, all under cGMP procedures and policies. We operate cleanroom space at Class 1,000 and smaller scale spaces at Class 100, all for clinical and commercial manufacturing. Our Quality System is regularly monitored to the current ISO 13485 standards by BSI. Novex is also registered with the FDA. Our customers are both national and international and have a good understanding of other regulatory agencies as well. Customers have the option of storing their products at and having Novex ship on their behalf.

Ofni Systems is an industry leader for 21 CFR Part 11 compliance and validation services. Their products for Part 11 compliant databases and spreadsheets are used by pharmaceutical, biotech and medical device companies across the globe, while its products for computer validation, auditing and FDA submissions ensure that their clients meet every requirement for electronic records and electronic signatures. The company provides live desktop support for superior customer support and training, and has been providing solutions to their clients since 1999. For more information, call (919) 844-2494 or visit http://www.OfniSystems.com.

Pairwise is a start-up food company that uses technology to break down the barriers that keep us from eating produce. At Pairwise, we are passionate about building a healthier world through better fruits and vegetables. Headquartered in Durham, NC, our team is made up of leaders in R&D, agriculture, and consumer products. Founded in 2017 and opened in 2018, Pairwise is working to deliver breakthrough innovation in agricultural sciences and in healthy consumer foods. Our team of proven leaders features Dr. Tom Adams, Chief Executive Officer (CEO), Dr. Haven Baker, Chief Business Officer (CBO), and eminent scientists Drs. Feng Zhang, David Liu and J. Keith Joung serve as advisors.

Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals collaborates with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers the best solutions to make every phase of the clinical trial process more efficient. With the people, insight and focus on operational excellence, we work With HeartTM every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference. For more information, visit parexel.com. Community Guidelines Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are: • Abusive, harassing or threatening to others. • Defamatory, offensive, obscene, vulgar or depicting violence. • Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs. • Sexually explicit or pornographic. • Fraudulent, deceptive, libelous, misleading or unlawful. • Referencing criminal or illegal activity. • Spamming. We reserve the right to remove any comments that do not adhere to our guidelines as well as report users who violate the rules of our page.

Small Molecules

The mission of PharmaLogika is to provide quality services and the highest level of expertise to start-up as well as established industry leaders from discovery, through clinical trials, to commercialization of ideas. Our goals include the deployment and management of consulting teams utilizing our online products, while maintaining the lowest possible overhead cost structures. Our target audience is primarily but certainly not exclusively small to medium size businesses within the Pharmaceutical, Biotech, and Medical Device industries.

Philip Morris International (PMI) is a leading international tobacco company working to deliver a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. Since 2008, PMI has invested more than USD 10.5 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. In November 2022, PMI acquired Swedish Match – a leader in oral nicotine delivery – creating a global smoke-free champion led by the companies’ IQOS and ZYN brands. As of September 30, 2023, PMI's smoke-free products were available for sale in 82 markets, and PMI estimates that approximately 19.7 million adults around the world had already switched to IQOS and stopped smoking. Smoke-free products account for approximately 36.2% of PMI’s total third-quarter 2023 net revenues. With a strong foundation and significant expertise in life sciences, PMI announced in February 2021 its ambition to expand into wellness and healthcare areas and, through its Vectura Fertin Pharma business, aims to enhance life through the delivery of seamless health experiences. For more information, please visit www.pmi.com and www.pmiscience.com. Our priority is to attract, support and keep with us diverse and unique individuals. Our global workforce of more than 69,000 people is one of our greatest strengths and the key to our success as a company. Our employees speak more than 80 languages and come from all corners of the world. PMI has also been certified as a “Global Top Employer” for the seventh consecutive year, in recognition of the high standards of excellence in our working environment and the exceptional development opportunities we offer. If you come into our offices or meet our people, you will quickly realize that at PMI everyone has the opportunity to make a difference and build phenomenal careers.

Phitonex uses a DNA nanotechnology platform to create highly customizable, deterministic fluorescent nanoparticles called Phitons.™

Plant Health Care is a leading provider of scientifically proven biological products for agriculture. The Company offers products to improve the health, vigor and yield of major field crops such as corn, soybeans, cotton and rice, as well as specialty crops such as fruits and vegetables. Our innovative line of patent protected products provides both economic and environmental benefits for our customers and capitalizes upon long-term trends towards natural systems and biological solutions to promote plant health and growth. Plant Health Care has global reach through operating subsidiaries and supply agreements with major industry an distribution partners.

Polarean is a revenue-generating medical imaging technology company revolutionizing pulmonary medicine through direct visualization of lung function by introducing the power and safety of MRI to the respiratory healthcare community. This community is in desperate need of modern solutions to accurately assess lung function. The Company strives to optimize lung health and prevent avoidable loss by illuminating hidden disease, addressing the global unmet medical needs of more than 500 million patients worldwide suffering from chronic respiratory disease. Polarean is a leader in the field of hyperpolarization science and has successfully developed the first and only hyperpolarized Xenon MRI inhaled contrast agent, XENOVIEW™, which is now FDA-approved in the United States. Polarean is dedicated to researching, developing, and commercializing innovative imaging solutions with its noninvasive and radiation-free pulmonary functional MRI platform. This comprehensive drug-device platform encompasses the proprietary Xenon gas blend, gas hyperpolarization system, as well as software and accessories, facilitating fully integrated modern respiratory imaging operations. Founded in 2012, with offices in Durham, NC, and London, United Kingdom, Polarean is committed to increasing global awareness of and broad access to its XENOVIEW MRI technology platform. For the latest news and information about Polarean, please visit www.polarean.com.

Precise Bio develops and commercializes 4D bio-fabricated functional tissues and organs that can save lives and improve its quality. We combine world-class tissue-engineering and transplantation experience with best-in-class bio-printing, to create a scalable bio-fabrication platform, that can overcome current industry challenges and make complex human organs available for transplantation.

Precision provides full sample management services in our Biological Freezers and Pharmaceutical stability chambers with four facilities across the United States. Our cGMP facilities (Wilson, NC; Hopedale, MA; Fort Lauderdale, FL; and El Segundo, CA) include the following features: • All Freezers, rooms, and Ambient Storage are fully validated. • 24/7/365 monitored Fire Alarm and Security system. • Access restricted with keyed access to main building, storage area, and individual chambers. Access doors are alarmed and camera monitored. • 21 CFR, Part 11 compliant monitoring system recording conditions with calibrated probes on all rooms/freezers. System does remote notification to alert personnel of alarms during non-business hours. • Backup generator to power the entire facility if there is a power outage, plus back-up conditioners/freezers are on hand if needed. Conditions available: Long-Term and Intermediate conditions of 25°C/40%Rh, 25°C/60%Rh, 30°C/65%Rh, 30°C/75%Rh, 30°C/35%Rh Accelerated storage of 40°C/not more than (NMT) 25%Rh, 40°C/75%Rh Refrigerated and Freezer storage conditions of 2°C - 8°C (5°C), -20°C, -80°C, LN2 Ambient storage conditions of 15°C - 30°C

Premier Nutrition Company (PNC) is one of the fastest-growing companies in the convenient nutrition space showing clear leadership in the category of protein shakes and protein powders. We make the brands Premier Protein, Dymatize, and PowerBar (which is sold internationally), and we are part of our holding company, BellRing Brands (NYSE: BRBR). We have a simple, yet powerful, formula for our success, which we've been nailing for over 15 years. We start with an organization powered by our company purpose—Changing Lives with Good Energy. Then our purpose-driven people are given the support and autonomy to develop and grow. Next, we are super-intentional about designing a culture where everyone feels like they truly connect and belong, which is one of our five company core values. Purpose-driven, connected employees who are consistently mastering new skills deliver amazing business results. Winning companies with amazing people and thriving cultures attract and retain top talent, so the cycle becomes self-reinforcing or what we call our regenerative culture. We don't mind sharing our formula since, as people who we believe in the power of changing lives with good energy, we think the world would be a better place if more workplaces treated adults like adults and gave them the platform to do the best work of their lives—alongside some truly amazing colleagues. Why don't more companies do this? It takes deep-in-your-bones conviction to your people, products, and purpose to pull it off. The results speak for themselves: We're certified as a Great Place to Work™ for the 7th year-running in 2023. We take care of our people, but here are some crowd-pleasers: Year-round ½ day Fridays, in-office massages, free lunches & snacks, dogs in the office, month-long cultural and diversity celebrations, monthly over-the-top in-office events, generous paid family leave regardless of gender, all positions bonus-eligible, and coaching conversations vs performance reviews.

Premier Research, a global clinical research, product development, and consulting company, is dedicated to helping innovators transform life-changing ideas and breakthrough science into new medical treatments. We offer strategic solutions across the entire development lifecycle, from pre-clinical through commercialization, specializing in smart study design and full-service clinical trial management. Leveraging technology and therapeutic expertise, we deliver clean, conclusive data with a focus on reducing development timelines, securing access to the right patients, and effectively navigating global regulations to ensure submission-ready results. As an organization that puts patients first, we pride ourselves on helping customers answer the unmet needs of patients across a broad range of medical conditions. Are you ready to make a real difference and help us transform this exciting industry? Follow our company page for more information about us and the work we do, and check out our current openings for your next career move!

We are a fully integrated pharmaceutical company located in Cranbury, engaged in developing and sales & marketing of generic pharmaceutical products in North American and South American markets. Since launching our first product, Benazepril in 2010, we have launched 11 products in U.S. market. Through reliable products’ quality, manufacturing capability and competitively strategic API resources from China, we have successfully reduced the medical cost for American buyers and help millions of patients against their illness.

We're a small but rapidly growing neurotechnology company based in Durham, North Carolina. Our vision is to enable and support outstanding basic and translational neuroscience research through innovative and affordable products. We launched XCSITE 100, our tDCS/tACS research solution, in 2016. Today, XCSITE 100 is used in leading brain stimulation labs across the United States. We are actively developing new technology and working with our stakeholders to provide new research solutions to enable cutting edge neuroscience.

Qualicaps manufactures empty two-piece capsules (gelatin and hypromellose) and encapsulation equipment under cGMP regulations for use by pharmaceutical, OTC and dietary-supplement manufacturers.

From Molecule to Market: Your Trusted Partner... Raybow USA (formerly PharmAgra) in Brevard, North Carolina, is a division of Jiuzhou Pharmaceutical, a CDMO with headquarters in Linhai, Taizhou City, in Zhejiang Province, China. Raybow USA, with over 20 years in R&D and Analytical Chemistry, is now your gateway to global power. Your big idea can start small and then fluidly scale up to medium, large, or super-sized production –all with the same North Carolina connections you’ve come to expect. Jiuzhou Pharma understands that bringing a molecule to market is not just about chemistry—it’s about trust, collaboration, and expertise. With years of proven excellence in the CDMO space, Jiuzhou Pharma has become a global leader in small molecule, nucleotide and peptide development. Raybow USA can help take your vision from concept to commercial reality—quickly, efficiently, and with the utmost precision. Let’s work together to shape the future of health! Why Jiuzhou Pharma? ✔ Comprehensive Solutions: support for your molecules from early-stage R&D to full-scale commercial manufacturing ✔ Expertise: deep scientific knowledge to deliver innovative and efficient solutions for small molecule and Tides CDMO services ✔ Global Reach, Local Focus: European and American subsidiaries tailor global CDMO services for specific regional markets ✔ Customer-Centric: committed to your success through partnerships based on transparency, reliability, and shared goals ###

Redbud Labs develops affordable microfluidic technologies that reduce lab workflow complexity without sacrificing performance. We have developed NAxtract, a cartridge-based automated sample preparation platform that sets the bar for ease-of-use. Reagents are contained in a single, disposable cartridge, capable of processing 8 samples in 30 minutes. This platform disrupts the sample prep market by making automation accessible: small footprint, zero overhead, no setup, no service contracts. Our first cartridge performs pathogen extraction from human biofluids. The platform will feature a menu of cartridges, making NAxtract is the most reliable and affordable sample prep solution available across a range of markets including liquid biopsy, infectious disease diagnostics, and genomic surveillance. At the core of our cartridges is a microfluidic agitation technology that overcomes diffusion-driven fluid dynamics at the microscale. Our patented Redbud Post technology enables microfluidic sample prep up to 1000x faster than conventional on-cartridge methods. Our intellectual property portfolio includes patents (18 granted, 36 pending), trade secrets, and exclusive supply. Redbud Labs headquarters, located in the Research Triangle Park, North Carolina is home to a nearly 8,000 sq.ft. custom-built lab space dedicated to production, prototyping, and general lab applications. Redbud Labs has dedicated BSL-2 facilities for cell culture, biological applications, and sample preparation with approximately 450 sq. ft. lab space isolated from shop and production at Redbud Labs headquarters. Redbud is certified ISO 9001 and 45001 for its quality, health and safety management system

The Rose Research Center multisite clinical research company under the direction of Jed E. Rose, Ph.D. Dr. Rose has a legacy of societal influence by way of co-inventing the nicotine skin patch and other treatments for smoking cessation. His primary research goals are to elucidate the biological mechanisms underlying tobacco addiction and to promote the development of more effective treatments. The Rose Research Center operates two premier research facilities in North Carolina, leading the way in clinical trials to eliminate smoking addiction. RRC specializes in product innovation, product development, pharmaceutical testing and development, and cessation and addiction research. Facilities: Two offices, both over 2000sq ft. located in Raleigh and Charlotte, North Carolina. Full time Research Coordinators and technicians at both locations alongside M.D.'s and P.A.'s specifically trained in research. Participation: 10,000 subjects in a proprietary database and a reach to nearly 5M individuals in N.C. RRC utilizes advanced in-house marketing techniques to recruit. Successful recruitment strategies are formulated and executed by our marketing department using television commercials, print advertising, social media, and a powerful set of recruitment websites. Standard Equipment: Emergency AED and on-site portable oxygen, ECG machines, Carbon monoxide monitors, Breathalyzer, Pulse oximeters, Clinical freezer storage (-86°C/-20°C) with 24-hour power backup and temperature monitoring, Compact analytical balance, High-pressure programmable syringe pumps for device and cigarette testing, Refrigerated centrifuge, Nebulizer, CReSS smoking topography, Medical exam tables, Laboratories equipped for clinical trial specimen collection and processing, Isolation negative pressure room and telescopic ventilation arm for smoking studies adjacent to a second room with a telescopic ventilation arm, Video recording and two-way audio monitoring of subject sessions.

Sequence Inc. provides turn-key consulting solutions and services for the biopharmaceutical manufacturing industry with a focus on Commissioning, Qualification and Validation (CQV) and Digital Solutions for facilities, utilities, equipment, computerized systems and labs. Through a fully functional, mock pharmaceutical manufacturing training facility, consultants are trained in a hands-on environment that is unique in the industry that includes both equipment and software. Founded in 2002, Sequence provides consulting solutions to clients across the U.S. and parts of Europe. The company is headquartered in the heart of RTP in Morrisville, NC with a second hub in Framingham, MA.

Spencer Health Solutions (www.spencerhealthsolutions.com) is transforming healthcare by moving care delivery to the home through the company's spencer® medication adherence and engagement platform. The spencer FDA Class I technology enables virtual care by connecting patients, clinicians, pharmacists, and family members digitally.

Sterling Pharmaceutical Services LLC is a full-service pharmaceutical contract manufacturer and formulation development expert that specializes in technology transfers, scale-up, and commercial manufacturing.

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers' delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

Tethis creates plant-based, compostable superabsorbents and rheology modifiers for use in hygiene, personal care, packaging, tissue & towel, energy, agriculture, and water treatment industries. Tethis allows companies to bring more sustainable products to market.

The company is working to improve the characteristeristics of trees.

Triangle Insights Group is a strategy consulting firm that delivers high-impact solutions to clients in the life sciences industry.

One of the leading cancer centers in the nation, UNC Lineberger Comprehensive Cancer Center is located in Chapel Hill, North Carolina. UNC Lineberger is one of only 57 National Cancer Institute-designated Comprehensive Cancer Centers and was rated as exceptional - the highest category - following its most recent NCI review. The center brings together some of the most exceptional physicians and scientists in the country to focus on advancing the prevention, early detection and treatment of cancer. With research that spans the spectrum from the laboratory to the bedside to the community, UNC Lineberger faculty work to understand the causes of cancer at the genetic and environmental levels, to conduct groundbreaking laboratory research, and to translate findings into pioneering and innovative clinical trials.

M3 Wake Research is a premier clinical trial network that has been conducting studies since 1984. With over 30 years of experience, the network's subject database for clinical trial participants has substantial potential and continues to expand as we grow our network across the country. The network comprises of premier investigational sites that are fully integrated and designed to deliver superior clinical trial experiences to patients, sponsors, and CROs. M3 Wake Research offers a full range of clinical trial services, from study design to study completion, to meet the needs of global biopharmaceutical, biotechnology, medical device, and pharmaceutical industry leaders. The board-certified physicians of M3 Wake Research have successfully completed over 7,000 clinical trials with integrity, human protection, and expeditious delivery of accurate evaluable data. Experience M3 Wake Research's uncompromising approach to superior quality in planning and executing each study according to regulations. The network consistently exceeds sponsor expectations for integrity, subject enrollment, human protection, and expeditious delivery of accurate evaluable data. Choose M3 Wake Research for clinical trials that meet and exceed your expectations.

White Labs provides yeast supplies, lab services and consulting to breweries, wineries and distilleries.

About Worldwide Clinical Trials  Worldwide Clinical Trials is a leading full-service global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new treatments. Our capabilities include bioanalytical laboratory services, Phase I-IV clinical trials, and post-approval and real-world evidence studies – all powered by our team members who bring their expertise and a collaborative, personalized approach to each clinical program. Anchored in our company’s scientific heritage, our dedicated therapeutic focus on cardiovascular, metabolic, neuroscience, oncology, and rare diseases, is applied to develop flexible plans and solve problems quickly for our customers. Our talented team of 3,000+ professionals spans 60+ countries, and embraces a culture of diversity, equity, inclusion, and belonging (DEI&B). We are united in cause with our customers to improve the lives of patients through new, innovative therapies. For more information on Worldwide, visit www.Worldwide.com.

ZenBio is a provider of advanced cell-based solutions and services to the life science, cosmetics, and personal care communities, specializing in adipose derived stem cells and human primary cells.